Prescribing Psychotropics bridges the gap between the complexities of drug pharmacokinetics and everyday clinical practice, providing clinicians more insight into how psychiatric drugs behave (or misbehave!) once their patients take them.
AUTISM IS: The Interactive Classroom Experience (An evidence-based curriculum for General Education K-12)
http://www.autismistheinteractiveclassroomexperience.com/
This curriculum has incorporated the common core standards. It is designed to sensitize students to kids with Autism. Ultimately, the students are encouraged to explore their thoughts and feelings about, and describe current interactions with, classmates on the Autism Spectrum. After exposure to the curriculum, the students are asked to explore the possible differences in their thoughts and feelings about people on the Spectrum. The changes in their perceptions and behavior towards their classmates positively impact the school environment.
You Might Also Enjoy...
Prescribing Psychotropics bridges the gap between the complexities of drug pharmacokinetics and everyday clinical practice, providing clinicians more insight into how psychiatric drugs behave (or misbehave!) once their patients take them.
As leaders we want to be kind while being effective, and this can be difficult. How do make sure that we do not become tired and angry but instead stay fresh and creative? Hear Zoe Kernohan Neely, Josh Feder MD & Jerri Lynn Hogg PhD in three mini videos.
This deep dive podcast breaks through the dogma of autism intervention and helps you to understand three main branches of autism intervention and their very different mechanisms, with a huge shift in our understanding of what works.
Positive Development is a start-up aiming to change the culture of the current state of autism treatment so that it opens the door for evidence-based developmental approaches for autism that are much more humane.
We break down three main autism intervention approaches, and provide you with information that will help you improve on your abilities to recognize which particular autism intervention might be best for a specific patient.
It's all over the internet: a new non-stimulant medication approved by the FDA for treatment of ADHD. but is Viloxazine (Qelbree) going to be a game changer? Find out!